Legal Research

Prompt

I am researching discretionary denial of an IPR under 35 U.S.C. § 314(a), with particular focus on the Director/PTAB’s consideration of “any other factors” or other circumstances bearing on the exercise of discretion, outside the conventional Fintiv parallel-litigation factors. I want to determine whether using an IPR primarily or substantially as commercial, transactional, settlement, acquisition, investment, licensing, or negotiating leverage—rather than as an alternative to pending patent litigation—is a circumstance supporting discretionary denial because institution would not be an efficient, fair, or appropriate use of the Board’s limited resources or would be inconsistent with the purposes of AIA review. Please conduct broad and creative PTAB research. Do not limit the search to published institution decisions because current Director discretionary-denial orders may contain little or no reasoning. Search and analyze: Precedential, informative, Director Review, and institution decisions discussing “other factors,” abuse of process, improper purpose, litigation leverage, settlement leverage, commercial leverage, harassment, opportunistic use of IPR, private disputes, efficient use of Board resources, integrity of the patent system, or petitions “outside the purpose” of AIA review. Patent Owner discretionary-denial briefs making similar arguments, especially where a petitioner was a former business partner, investor, potential acquirer, licensee, collaborator, diligence participant, NDA counterparty, competitor, or recipient of confidential technical information. Cases involving a petitioner that had not been sued for infringement and where the Board or Director considered the petitioner’s actual commercial purpose, freedom-to-operate justification, timing, relationship with the patent owner, or surrounding circumstances. Decisions and briefs citing or applying Magnolia Medical Technologies, Inc. v. Kurin, Inc.; OpenSky Industries, LLC v. VLSI Technology LLC; Patent Quality Assurance LLC v. VLSI Technology LLC; iRhythm Technologies, Inc. v. Welch Allyn, Inc.; General Plastic; Fintiv factor 6; 35 U.S.C. §§ 314(a), 316(a)(6), and 316(b); and 37 C.F.R. § 42.12. Any authority discussing whether IPR should remain a “true alternative” to litigation, whether the Office should avoid expending resources to resolve a predominantly private commercial dispute, or whether institution may be denied where the proceeding is being used to create bargaining power unrelated to an existing infringement case. Recent Patent Owner briefs filed under the 2025–2026 Director discretionary-denial process, even if the ultimate Director order is summary. Where a summary denial followed a Patent Owner brief making this type of argument, identify the brief and outcome but clearly state that the summary order does not establish that the Director adopted any particular argument. Any contrary authority holding that economic motive, settlement motive, competitive motive, or the absence of infringement litigation is insufficient by itself to justify denial. I need the strongest counterarguments as well as favorable authority. Please distinguish carefully among: binding or precedential authority; informative/nonprecedential PTAB decisions; Director Review decisions; Patent Owner briefs or party arguments that are useful only as persuasive templates; summary discretionary-denial orders from which no specific reasoning can properly be inferred. For each useful authority, provide the case name, IPR number, paper number, date, quotation or precise proposition, procedural posture, and Westlaw citation/link or PTAB docket source if available. Also identify the best 5–10 authorities and Patent Owner briefs for supporting this proposed argument: The Director should deny institution where the totality of the circumstances shows that the petitioner invoked IPR not to serve as an alternative forum for resolving an infringement dispute, but as transactional leverage following unsuccessful efforts to acquire, invest in, or obtain increasingly sensitive technical information from the patent owner/licensee. Using the Office’s limited adjudicatory resources to increase bargaining pressure in a failed commercial transaction is inconsistent with the economy, efficient administration of the Office, integrity of the patent system, and public purposes of AIA review. Finally, suggest the most defensible way to frame this argument without overreaching into an accusation of sanctionable abuse, extortion, bad faith, or misconduct unless the authorities and evidence actually support such a characterization. Identify factual distinctions that would make this case stronger or weaker, and recommend additional evidence that should be developed to support the discretionary-denial request.